Progressive Macular Hypomelanosis
Küçük Resim Yok
Tarih
2011
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
DERI ZUHREVI HASTALIKLAR DERNEGI
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Progressive macular hypomelanosis (PMH) was initially described and named by Guillet in 1988. PMH is characterized by asymptomatic, ill-defined, nummular, non-scaly, hypopigmented macules, localized predominantly on the trunk. PMH is mostly seen in adolescents and young females. The etiopathogenesis of PMH is still unknown. The red follicular fluorescence becomes visible in the hypopigmented macules under Wood's lamp but is absent in normal adjacent skin. The histopathologic findings in PMH are usually non-specific, but a common feature is the decreased melanin content in the hypopigmented macules compared to the normal skin. No effective therapy is currently known. Phototherapy was found to be effective for the control of PMH; however, it does not prevent recurrence of the disease. In this paper, we aimed to review the etiopathogenesis, clinical findings, histopathology, differential diagnosis and treatment options of PMH.
Açıklama
Anahtar Kelimeler
Progressive macular hypomelanosis, pigmentation disorders
Kaynak
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY
WoS Q Değeri
N/A
Scopus Q Değeri
Cilt
45
Sayı
2
